Filling the need for trusted information on national health issues…

The cost of prescription drugs remains a hot-button issue for consumers and policymakers. The vast majority of the public views drug prices as unreasonable, and one in four people taking prescription drugs report difficulty affording their medication. Recently, the Trump Administration, Congress and state and federal policy makers have focused renewed attention on potential actions to address drug costs, including regulatory and legislative changes that affect Medicare, Medicaid and private insurance.  This collection includes KFF research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.
  • Your Selections:

Refine Results

date

Topics

Tags

Content Type

Program

Medicare Part D in 2018: The Latest on Enrollment, Premiums, and Cost Sharing

This brief about the 2018 Medicare Part D marketplace analyzes the latest data on Medicare drug coverage and trends over time, including both stand-alone prescription drug plans and Medicare Advantage drug plans. The analysis focuses on enrollment, premiums, cost sharing, and the low-income subsidy.

Kaiser Health Tracking Poll: Preview of the Role of Health Care in the 2018 Midterm Campaigns

The latest KFF Health Tracking Poll finds health care ranking among the top issues voters want to hear candidates talk about during their congressional campaigns, with health care cost ranking as the top health care issue for voters across partisanship. However, for many voters, including one-third of Republican voters, a candidate’ position on President Trump will make the biggest difference in how they vote in 2018. This month’s poll also takes an in-depth look at voters who say a candidate’s position on health care will be the “most important factor” in their 2018 congressional vote choice, otherwise known as “health care voters.”

Searching for Savings in Medicare Drug Price Negotiations

In response to higher drug spending growth and heightened attention to drug prices, some policymakers have proposed allowing Medicare to negotiate the price of prescription drugs. This issue brief provides a short history of this proposal, describes various approaches, and assessments of their potential savings from the Congressional Budget Office (CBO), and considers the prospects for action in the future.

Prescription Drugs

The cost of prescription drugs remains a hot-button issue for consumers and policymakers. The vast majority of the public views drug prices as unreasonable, and one in four people taking prescription drugs report difficulty affording their medication. Recently, the Trump Administration, Congress and state and federal policy makers have focused renewed…

Kaiser Health Tracking Poll – March 2018: Views on Prescription Drug Pricing and Medicare-for-all Proposals

More than a year into President Trump’s presidency, the March Kaiser Health Tracking Poll gauges the public’s top priorities for the president and Congress to do in the coming months. This month’s poll also measures perceptions on the cost of prescription drugs, attitudes towards policymakers’ actions to address drug prices, and views of pharmaceutical companies. In addition, with the 2018 midterm elections less than 8 months away, the KFF poll asks how important a national health plan is to voters.

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.